Johnson John Paul
SEC CIK 1782040 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EVH | Evolent Health, Inc. | CFO | 309.2K | — | $1.97M | 17 | 2022-03-01 | 2025-07-01 |
Most active insiders at EVH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McCarthy Daniel Joseph | Pres | — | $329.5K |
| 2 | Springstubb Brendan B | Dir | $38.2K | — |
| 3 | Glass Russell Monroe | Dir | — | — |
| 4 | Ajayi Toyin | Dir | — | — |
| 5 | Ramos Mario | CFO | — | — |
| 6 | KECK KIM | Dir | — | — |
| 7 | Shams Aammaad | CAO | — | — |
| 8 | Jelinek Richard M | Dir | — | — |
| 9 | Blackley Seth | CEO, Dir | — | — |
| 10 | Weinberg Jonathan | GC | — | — |
Johnson John Paul made no open-market trades at EVH in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +25.5K | 309.2K | +9% | $0 | |
| M | 2025-03-04 | 2025-03-03 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +148.7K | 251.1K | +145% | $0 |
| M | 2025-03-04 | 2025-03-01+ | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $8.83 | -36.1K | 162.0K | -18% | -$318.8K |
| 2024-08-26 | 2024-08-22 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | S - Sale | $30.00 | -44.7K | 171.2K | -21% | -$1.34M | |
| M | 2024-03-05 | 2024-03-01+ | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $34.41 | -20.2K | 224.9K | -8% | -$696.2K |
| 2024-03-05 | 2024-03-01 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +12.1K | 236.1K | +5% | $0 | |
| 2024-02-26 | 2024-02-22 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $33.03 | -20.0K | 224.0K | -8% | -$660.8K | |
| 2024-02-26 | 2024-02-22 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +44.0K | 244.0K | +22% | $0 | |
| M | 2023-03-03 | 2023-03-01+ | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $35.18 | -12.7K | 200.0K | -6% | -$446.8K |
| 2023-03-03 | 2023-03-01 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +20.4K | 212.7K | +11% | $0 | |
| 2023-02-23 | 2023-02-21 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $28.08 | -20.0K | 192.3K | -9% | -$562.3K | |
| 2023-02-23 | 2023-02-21 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +44.0K | 212.3K | +26% | $0 | |
| 2022-08-18 | 2022-08-17 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | S - Sale | $34.11 | -18.4K | 168.3K | -10% | -$628.8K | |
| DM | 2022-03-04 | 2022-03-02+ | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $27.54 | -41.4K | 186.8K | -18% | -$1.14M |
| D | 2022-03-04 | 2022-03-02 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | M - OptEx | $0.00 | +71.7K | 228.1K | +46% | $0 |
| 2022-03-03 | 2022-03-01 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | A - Grant | $0.00 | +24.0K | 160.9K | +18% | $0 | |
| 2022-03-03 | 2022-03-01 | EVH | Evolent Health, Inc. | Johnson John Paul | CFO | F - Tax | $27.40 | -4,510 | 156.4K | -3% | -$123.6K |
Purchase Sale Sale after option exercise All abbreviations